Hepatitis C Seroprevalence Among HIV-Infected Childbearing Women in New York State in 2006

详细信息    查看全文

• 作者：L. Ghazaryan ; L. Smith ; M. Parker ; C. Flanigan…
• 关键词：Hepatitis C ; HIV ; Pregnant ; New York State ; Seroprevalence
• 刊名：Maternal and Child Health Journal
• 出版年：2016
• 出版时间：March 2016
• 年：2016
• 卷：20
• 期：3
• 页码：550-555
• 全文大小：341 KB
• 参考文献：1.Denniston, M. M., et al. (2014). Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003–2010. Annals of Internal Medicine, 160(5), 293–300.PubMedCentral CrossRef PubMed
  2.Hellard, M., Sacks-Davis, R., & Gold, J. (2009). Hepatitis C treatment for injection drug users: A review of the available evidence. Clinical Infectious Diseases, 49(4), 561–573.CrossRef PubMed
  3.Grebely, J., & G.J. Dore, G. J. (2011). What is killing people with hepatitis C virus infection? In Seminars in Liver Diseases.
  4.Trooskin, S. B., et al. (2015). Results from a Geographically Focused, Community-Based HCV Screening, Linkage-to-Care and Patient Navigation Program. Journal of General Internal Medicine, 30(7), 950–957.CrossRef PubMed
  5.Alter, M. J., et al. (1999). The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. New England Journal of Medicine, 341(8), 556–562.CrossRef PubMed
  6.Arshad, M., El-Kamary, S., & Jhaveri, R. (2011). Hepatitis C virus infection during pregnancy and the newborn period–are they opportunities for treatment? Journal of Viral Hepatitis, 18(4), 229–236.CrossRef PubMed
  7.Yeung, L. T., King, S. M., & Roberts, E. A. (2001). Mother-to-infant transmission of hepatitis C virus. Hepatology, 34(2), 223–229.CrossRef PubMed
  8.Dunkelberg, J., et al. (2014). Hepatitis B and C in pregnancy: A review and recommendations for care. Journal of Perinatology, 34, 882–891.CrossRef PubMed
  9.Roberts, E. A., & Yeung, L. (2002). Maternal-infant transmission of hepatitis C virus infection. Hepatology, 36(5B), s106–s113.CrossRef PubMed
  10.Thaler, M., et al. (1991). Vertical transmission of hepatitis C virus. The Lancet, 338(8758), 17–18.CrossRef
  11.Zanetti, A. R., et al. (1995). Mother-to-infant transmission of hepatitis C virus. Lombardy study group on vertical HCV transmission. Lancet, 345(8945), 289–291.CrossRef PubMed
  12.Birkhead, G. S., et al. (2010). Progress in prevention of mother-to-child transmission of HIV in New York State: 1988–2008. Journal of Public Health Management and Practice, 16(6), 481–491.CrossRef PubMed
  13.CDC. (2013). Testing for HCV infection: An update of guidance for clinicians and laboratorians. Morbidity and Mortality Weekly Report, 62(18), 362.
  14.Heinze, G., & Schemper, M. (2002). A solution to the problem of separation in logistic regression. Statistics in Medicine, 21(16), 2409–2419.CrossRef PubMed
  15.Frederick, T., et al. (2009). Factors associated with prevalent hepatitis C infection among HIV-infected women with no reported history of injection drug use: The Women’s Interagency HIV Study (WIHS). AIDS patient care and STDs, 23(11), 915–923.PubMedCentral CrossRef PubMed
  16.Hagan, H., Thiede, H., & Des, D. C. (2005). Jarlais, HIV/hepatitis C virus co-infection in drug users: Risk behavior and prevention. AIDS, 19, S199–S207.CrossRef PubMed
  17.AASLD/IDSA HCV Guidance Panel. (2015). Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. Hepatology, 62(3), 932–954.CrossRef
  18.Alter, M. J., et al. (1998). Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR. Morbidity and Mortality Weekly Report, 47(1), 1–39.
  19.Smith, B. D., et al. (2012). Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945–1965. MMWR Recommendations and Reports, 61(RR-4), 1–32.PubMed
  20.Santiago-Munoz, P., et al. (2005). Prevalence of hepatitis B and C in pregnant women who are infected with human immunodeficiency virus. American Journal of Obstetrics and Gynecology, 193(3 Pt 2), 1270–1273.CrossRef PubMed
  
• 作者单位：L. Ghazaryan (1)
  L. Smith (2)
  M. Parker (3)
  C. Flanigan (4)
  W. Pulver (2)
  T. Sullivan (5)
  A. Carrascal (6)
  
  1. Surveillance and Special Projects Unit, Bureau of STD Prevention and Epidemiology, AIDS Institute, New York State Department of Health, ESP, Corning Tower, Albany, NY, 12237, USA
  2. Division of Epidemiology, Evaluation and Research, New York State Department of Health, Corning Tower, ESP, Albany, NY, 12237, USA
  3. Bloodborne Viruses Laboratory, Wadsworth Center, New York State Department of Health, 120 New Scotland Avenue, Albany, NY, 12208, USA
  4. Viral Hepatitis Section, AIDS Institute, New York State Department of Health, ESP, Corning Tower Room 429, Albany, NY, 12237, USA
  5. Wadsworth Center, New York State Department of Health, 120 New Scotland Avenue, Albany, NY, 12208, USA
  6. Cancer Control, American Cancer Society, Eastern Division, One Penny Lane, Latham, NY, 12110, USA
  
• 刊物主题：Public Health; Sociology, general; Population Economics; Pediatrics; Gynecology; Maternal and Child Health;
• 出版者：Springer US
• ISSN：1573-6628

文摘

Objective To identify factors associated with maternal hepatitis C virus (HCV) seroprevalence and transmission of HCV as identified by qualitative HCV ribonucleic acid (RNA) in the infants of human immunodeficiency virus (HIV) infected women delivering in New York State (NYS) in 2006. Study Design In this retrospective cohort study of HIV-exposed infants born in NYS, leftover infant plasma from HIV diagnostic testing was de-identified and tested for HCV. If HCV antibodies were detected, a second specimen collected when the infant was >2 months old was tested for HCV qualitative RNA. Multivariate logistic regression was used to identify factors associated with HCV seropositivity. Results In a final sample of 553 live birth events with perinatal HIV exposure, 21 (3.8 %) of tested infant specimens had HCV antibodies indicative of maternal HCV seropositivity. Maternal age at delivery of >35 years, Hispanic ethnicity, white race and injection drug use (IDU) were significantly associated with HCV seropositivity in multivariate analysis. No cases of HCV vertical transmission were identified among HCV exposed infant specimens. Conclusions This statewide population-based study of HIV-infected childbearing women shows HCV seroprevalence of 3.8 %. Maternal age of >35 years and IDU are the strongest predictors of HCV seropositivity. Although no viral transmission was documented, more comprehensive longitudinal testing would be required to conclude that HCV transmission did not occur. Keywords Hepatitis C HIV Pregnant New York State Seroprevalence